5 completed, 4 unknown, 1 enrolling by invitation. 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Ya-Wei Xu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases Hematological indicators, Serological indicators in patients with myocardial infarction, Levels of biomarkers in blood of patients with acute myocardial infarction - Angiocardiography, Heart Failure | Enrolling by invitation | Ya-Wei Xu | 300 | 2023-10-17 | 2024-11-15 | |
| Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries Cardiac Shock Wave Therapy - Myocardial Infarction With Non-obstructive Coronary Arteries, Cardiac Shock Wave Therapy | Not applicable | Unknown | Ya-Wei Xu | 56 | 2023-07-01 | 2023-11-18 |
| Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak. Thrombolytic, percutaneous coronary stenting - STEMI - ST Elevation Myocardial Infarction | Not applicable | Unknown | Ya-Wei Xu | 120 | 2022-04-01 | 2022-05-26 |
| Exploring HRV in Antarctic Overwintering Members of Asia Antarctic environment - Heart Rate Variability | Completed | Ya-Wei Xu | 22 | 2021-03-01 | 2024-04-26 | |
| Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism Venous Thromboembolism (VTE) | Unknown | Ya-Wei Xu | 4000 | 2019-06-01 | 2019-11-29 | |
| Study of Safety and Efficacy of a Left Atrial Appendage Occulder The Left Atrial Appendage Occulder of Shanghai Push Medical Device Technology CO.td - Non-valvular Atrial Fibrillation, Stroke | Phase 1 / Phase 2 | Unknown | Ya-Wei Xu | 154 | 2017-01-01 | 2016-10-18 |
| SHR Predicts CMD in Patients with CCS caIMR - Coronary Microvascular Dysfunction (CMD), Index of Microvascular Resistance | Completed | Ya-Wei Xu | 379 | 2015-06-01 | 2024-11-21 | |
| Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF The study involved a comparison of clinical characteristics, medical history, laboratory biomarkers, echocardiographic measurements, angiographic findings, and clinical outcomes between two groups. - Heart Failure With Preserved Ejection Fraction | Completed | Ya-Wei Xu | 584 | 2015-03-09 | 2024-12-02 | |
| Prognostic Significance of CMD Assessed by IMR in HCM Patients caIMR - Coronary Cicrovascular Dysfunction, Hypertrophic Cardiomyopathy Patients | Completed | Ya-Wei Xu | 191 | 2014-09-13 | 2024-01-08 | |
| Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study Diuretic，Betaloc，antiplatelet drugs - Left Ventricular Diastoic Dysfunction Cohort Study | Completed | Ya-Wei Xu | 1920 | 2014-07-10 | 2021-04-26 |
Cardiomyopathy, Hypertrophic (1) · Depression (1) · Heart Failure (1) · MINOCA (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · ST Elevation Myocardial Infarction (1) · Stroke (1) · Venous Thromboembolism (1)
Fibrinolytic Agents (1) · Health Records, Personal (1)
China (5)
Dachun Xu, Ph.D (1) · Yawei Xu, Doctor (1) · Yawei Xu, MD, PHD (1)